Brochure
25 Apr 2025

COMPANY PRESENTATION

PDF 9.5 MB

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production

6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs

Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate

Content provided by our supplier

GENOVIOR BIOTECH CORPORATION

  • Country/Region:
    Taiwan
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)

Other Content from GENOVIOR BIOTECH CORPORATION (2)